Skip to main content
Equibles

BRIDGEWAY CAPITAL MANAGEMENT, LLC

Position in ANIK — Anika Therapeutics, Inc.

CIK 1107261 HOUSTON, TX
Back to ANIK Full portfolio

Position in ANIK

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$256,025
+$2,275 QoQ
Shares Held
17,500
0.0% QoQ
Ownership
0.131%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#69
of 134 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ANIK Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

BRIDGEWAY CAPITAL MANAGEMENT, LLC holds $34,784,557 across 16 Drug Manufacturers - Specialty & Generic names. ANIK ranks #12 (0.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 PCRX
Pacira BioSciences, Inc.
 411,373 $10,436,533
2 PRGO
PERRIGO Co plc
 830,134 $8,625,092
3 AMPH
Amphastar Pharmaceuticals, Inc.
 298,954 $6,032,891
4 AMRX
Amneal Pharmaceuticals, Inc.
 106,449 $1,842,632
5 IRWD
Ironwood Pharmaceuticals Inc
 389,793 $1,641,028
6 INDV
Indivior Pharmaceuticals, Inc.
 35,000 $1,436,050
7 UTHR
UNITED THERAPEUTICS Corp
 2,620 $1,419,594
8 BIOA
BioAge Labs, Inc.
 42,000 $1,029,420

All Filings in ANIK

Export CSV
5 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $256,025 17,500
2026-03-31 $253,750 17,500
2025-12-31 $168,175 17,500
2025-09-30 $164,500 17,500
2025-06-30 $185,150 17,500